North America remains a dominant regional market for hypercalcemia treatment due to rising healthcare expenditure, growing awareness of metabolic disorders, and the increasing burden of chronic diseases. The region benefits from a well-established healthcare ecosystem, advanced diagnostic capabilities, and continuous innovation in therapeutic development. Market Overview According to market...